AC
NASDAQ · ACRV
Acrivon Therapeutics, Inc. Common Stock
Healthcare · Biotechnology
$1.70
Down-$0.13 (-7.10%)
Updated Sep 17, 2026, 4:08 AM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 47.65M
- P/E ratio
- -0.71
- Dividend yield
- 0.00%
- 52-week range
- $1.27 – $2.39
- Volume
- 765.12K
- Avg. volume
- 1.62M
Price performance
ACRV price history
1M range · 20 trading sessions · Daily adjusted prices
ACRV closed at $1.70 after 20 trading sessions, down 28.87% for the selected period.
- Last close
- $1.70
- Period change
- -28.87%
- Period low
- $1.70
- Period high
- $2.39
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.85 | $1.90 | $1.695 | $1.70 | 765.12K |
| Sep 15, 2026 | $1.97 | $1.975 | $1.805 | $1.83 | 304.88K |
| Sep 14, 2026 | $1.98 | $1.99 | $1.94 | $1.96 | 208.34K |
| Sep 11, 2026 | $2.05 | $2.06 | $1.95 | $2.00 | 461.59K |
| Sep 10, 2026 | $2.03 | $2.06 | $1.96 | $2.04 | 323.97K |
| Sep 9, 2026 | $2.10 | $2.17 | $1.99 | $1.99 | 239.12K |
| Sep 8, 2026 | $2.13 | $2.175 | $2.07 | $2.10 | 129.98K |
| Sep 4, 2026 | $2.06 | $2.14 | $2.055 | $2.13 | 184.6K |
| Sep 3, 2026 | $2.15 | $2.15 | $2.045 | $2.06 | 118.79K |
| Sep 2, 2026 | $2.07 | $2.20 | $2.05 | $2.15 | 131.32K |
| Sep 1, 2026 | $2.07 | $2.125 | $2.025 | $2.07 | 356.52K |
| Aug 31, 2026 | $2.04 | $2.11 | $2.0209 | $2.09 | 160.29K |
| Aug 28, 2026 | $2.16 | $2.1899 | $2.05 | $2.06 | 217.93K |
| Aug 27, 2026 | $2.11 | $2.20 | $2.08 | $2.15 | 188.35K |
| Aug 26, 2026 | $2.17 | $2.19 | $2.08 | $2.08 | 160.13K |
| Aug 25, 2026 | $2.19 | $2.255 | $2.17 | $2.18 | 243.11K |
| Aug 24, 2026 | $2.19 | $2.225 | $2.06 | $2.20 | 171.49K |
| Aug 21, 2026 | $2.21 | $2.31 | $2.18 | $2.21 | 361.33K |
| Aug 20, 2026 | $2.33 | $2.37 | $2.17 | $2.20 | 499.43K |
| Aug 19, 2026 | $2.06 | $2.39 | $2.06 | $2.39 | 731.49K |
Latest ACRV news
The latest Smart Investors Daily articles mentioning ACRV.
Stock researchResearch & News · SID Coverage
Loading stock research…
